In summary, we used fresh cultures of treatment-naïve organotypic breast tumors that closely mimic the disease in patients[22] to identify survivin family proteins as drivers of primary doxorubicin resistance across breast cancer subgroups. The gene discussed is BIRC5; the disease is breast neoplasm.